Drawing for ADAPT CLICK

USPTO serial 79243912

ADAPT CLICK

Reviewed by CopyMark Law Group

Status 601
Filing date
Status date
Registration date
—
Examiner
EISNACH, MICHAEL PATRICK
Law office
TMEG LAW OFFICE 104 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADAPT CLICK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa C. Pavento

Lisa C. Pavento Meunier Carlin & Curfman LLC999 Peachtree St. NESuite 1300Atlanta, GA 30309

Goods and services

ClassDescriptionStatusFirst use
001Filtering materials being chemical, mineral, vegetable substances and unprocessed plastics for use in the field of life sciences research; chemical preparations and materials for film making, photography and printing; unprocessed plastics; adhesives for industrial purposes; growing media, fertilizers and chemicals for use in agriculture, horticulture and forestry; detergents for use in manufacturing processes and for industrial purposes; chemicals substances, chemical materials and chemical preparations as well as natural elements, in particular enzymes for industrial purposes, enzyme preparations for industrial purposes; salts for industrial purposes; unprocessed artificial and synthetic resins; starches for use in manufacturing and industry; chemical and organic compositions for use in the manufacture of food and beverages, in particular ferments for chemical purposesACTIVE—
005Dietary supplements; medicated dentifrices; medical and veterinary preparations and articles, namely, diagnostic compositions, enzymes for medical purposes, enzyme preparations for medical purposes, diagnostic preparations and materials, pharmaceuticals for the treatment of genetic and immune diseases, namely, lysosomal storage diseases, pharmaceuticals for the treatment of Fabry diseases, medical dressings, coverings and cotton buds for medical purposes, pregnancy test kits for home use and dipstick test kits in the nature of home pregnancy test kitsACTIVE—
042IT services, namely, software development, programming and implementation, and computer analysis and diagnostics; science and technology services, in particular industrial analysis and research services; information and consultancy relating to the aforesaid services, as far as included in this classACTIVE—
044Animal healthcare services; animal grooming services; human healthcare services, in particular medical services relating to the removal, treatment and processing of human cells, health screening; human hygiene and beauty care; information and consultancy relating to the aforesaid services, as far as included in this classACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 5, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 20, 2022FINTFINAL DECISION TRANSACTION PROCESSED BY IB—
Nov 3, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB—
Nov 2, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 2, 2021MAB1ABANDONMENT NOTICE E-MAILED - EXPRESS ABANDONMENT—
Nov 2, 2021ABN1ABANDONMENT - EXPRESS MAILED—
Nov 1, 2021EXARTEAS EXPRESS ABANDONMENT RECEIVED—
Oct 20, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Oct 20, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Oct 20, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 20, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Oct 20, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 8, 2021RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Dec 8, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 8, 2020RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Jun 4, 2020ALIEASSIGNED TO LIE—
Apr 10, 2020OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 25, 2020OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 25, 2020OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 16, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
May 16, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 16, 2019GNSLLETTER OF SUSPENSION E-MAILED—
May 16, 2019CNSLSUSPENSION LETTER WRITTEN—
May 14, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 14, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 14, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 8, 2018RFNTREFUSAL PROCESSED BY IB—
Nov 16, 2018RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 16, 2018RFRRREFUSAL PROCESSED BY MPU—
Nov 6, 2018RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 5, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 2, 2018MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 29, 2018DOCKASSIGNED TO EXAMINER—
Oct 29, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 25, 2018REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance